**BSE: 526967 | NSE Listed** **Headquarters: Ahmedabad, Gujarat** Heera Ispat Limited is an Indian public limited company currently undergoing a radical strategic transformation. Historically a player in the **Metal and Ferrous** industry, the company is transitioning from a period of operational cessation toward a diversified global trading and **Export-Import (EXIM)** model. This pivot involves a massive expansion of its capital base, a restructuring of its promoter group, and an entry into the **Agro-commodities** sector. --- ### **Strategic Pivot: The New Diversified Trading Mandate** To address the lack of commercial activity in its legacy steel business, Heera Ispat has significantly altered its **Main Object Clause** in the **Memorandum of Association (MoA)**. The company is now authorized to operate as an exporter, importer, distributor, and commission agent across a vast array of sectors: | Category | Key Products & Commodities | | :--- | :--- | | **Agro Products** | Spices, **psyllium seeds/husk**, pulses, grains, dry fruits, oilseeds, and edible oils. | | **Industrial & Metals** | Metal alloys, iron, steel, stainless steel, pipe fittings, ores, scraps, and metallurgical residues. | | **Consumer Goods** | Readymade garments, handicrafts, household articles, textiles, and leather goods. | | **Specialized Items** | Chemicals, engineering goods, machine tools, electronic products, and medical drugs (Ayurvedic/Allopathic). | While the company maintains a "ready-to-start" status for its steel production unit—targeting the manufacture of bars and wires using **imported coal** and **pig iron**—the immediate focus is on high-potential trading opportunities in **Agro commodities** to unlock shareholder wealth. --- ### **Capital Restructuring & Aggressive Fund Raising** The Board has approved several financial measures to facilitate this new growth phase and address the current liquidity crunch: * **Authorized Share Capital:** Increased nearly tenfold from **₹6 Crore** to **₹56 Crore** (Approved Jan 2025). * **Borrowing Limits:** Enhanced to **₹500 Crore** to fund future expansion and working capital requirements. * **Rights Issue:** Approved raising up to **₹49.90 Crore** through the issuance of equity shares. * **Debt-to-Equity Conversion:** Authorization to convert unsecured loans from directors and third parties up to **₹25 Crore** into equity. * **General Fund Raising:** Board mandate to raise up to **₹50 Crore** via **Qualified Institutional Placement (QIP)**, **Private Placement**, or **Preferential Allotment**. --- ### **Financial Performance & Solvency Metrics** The company is currently navigating severe financial stress, reporting **zero revenue from operations** for the most recent fiscal cycles. The capital structure has deteriorated into **negative equity** due to accumulated losses. **Key Financial Indicators (₹ in Thousands):** | Particulars | As at 31st March 2025 | As at 31st March 2024 | As at 31st March 2023 | | :--- | :--- | :--- | :--- | | **Total Debt** | **9,900.00** | **594.35** | **554.32** | | **Total Equity** | **(5,616.87)** | **(970.97)** | **668.02** | | **Debt to Equity Ratio** | **(1.76)** | **(0.61)** | **0.83** | | **Net Loss** | **(4,645.90)** | **(1,638.99)** | **(1,045.21)** | * **Return on Capital Employed (ROCE):** Declined from **7.07** in FY 2021-22 to **2.29** in FY 2022-23. * **Dividend Policy:** No dividends have been recommended due to the erosion of net worth and carried forward losses. --- ### **Operational Infrastructure & Governance** The company has centralized its administration to support its new trading mandate and professionalize its board. * **Registered Office:** Relocated effective March 1, 2025, to **A 1327 Sun West Bank, Ashram Road, Ahmedabad, Gujarat, 380009**. * **Promoter Reclassification:** In **December 2025**, the BSE approved the reclassification of **Dharmeshkumar Rameshchandra Mistry** from "Promoter" to "Public" category. * **Board Appointments:** * **Rajesh Chinubhai Sutaria:** Independent Director (Term until July 2028). * **Muskan Rana:** Non-Executive Woman Director. * **Compliance Framework:** Financials are prepared under **Indian Accounting Standards (Ind AS)**. A **Rights Issue Committee** was constituted in early 2025 to oversee capital market activities. --- ### **Critical Risk Factors & Auditor Concerns** Investors should note that statutory auditors have issued a **Qualified Opinion** regarding the company’s status as a **Going Concern**. **1. Operational & Financial Risks:** * **Erosion of Net Worth:** The company’s entire net worth is eroded, and core assets (factory buildings, plant, and machinery) have been liquidated. * **Material Uncertainty:** Auditors highlight that the company lacks sufficient cash flow to sustain operations, though management continues to prepare results on a "going concern" basis citing future negotiations. * **Exceptional Items:** A provision of **₹10 Lakh** was made against a **BSE penalty** of **₹53.91 Lakh** (including GST) for non-compliance with SEBI (LODR) regulations. A waiver application is pending. **2. Regulatory & Governance Deficiencies:** * **Board Composition:** Historically, the company has faced challenges maintaining a duly constituted board, including the lack of a **Whole-time Company Secretary** and an **Internal Auditor** (as per Section 139). * **Infrastructure:** The official website has been reported as **non-functional**, and there have been failures in publishing statutory notices in newspapers. **3. Market & Macroeconomic Risks:** | Risk Category | Primary Drivers | | :--- | :--- | | **Market Volatility** | Fluctuations in **Sponge Iron** prices and excess market supply. | | **Input Costs** | Volatility in **Imported Coal** prices and **USD-INR** exchange rates. | | **Regulatory Shifts** | Changes in **Tariff policy guidelines** on power generation and SERC price caps. | ### **Future Outlook** Heera Ispat’s survival depends on the successful execution of its **Rights Issue** and the activation of its new **Agro-trading** mandate. Management’s strategy relies on identifying "remunerative prices" and "commercially viable" orders before resuming full-scale manufacturing or trading operations. The induction of funds via **Joint Ventures** or further share issuance remains a primary objective to stabilize the balance sheet.